Today: 17 May 2026
Estée Lauder stock slips in premarket after 8.5% Monday slide as travel-retail worries creep back
3 March 2026
2 mins read

Estée Lauder stock slips in premarket after 8.5% Monday slide as travel-retail worries creep back

NEW YORK, March 3, 2026, 06:05 EST — Premarket

  • EL slipped roughly 2% in early premarket trading, following Monday’s 8.5% tumble.
  • Sentiment in the beauty sector has shifted, with peers flagging concerns about margins and ongoing turbulence in travel retail.
  • Eyes move next to the March 16 dividend payout, then the earnings release and call set for May 1.

Estée Lauder Companies Inc shares slipped another 2.2% Tuesday morning, extending Monday’s 8.5% drop. The stock was indicated near $98.00 ahead of the bell, from a $100.19 close. Monday’s session saw the price move between $99.98 and $106.95, with volume reaching 5.25 million shares. Pre-market action, which precedes the 9:30 a.m. ET open, tends to be volatile on lighter trading.

Investors are recalibrating expectations for prestige beauty stocks, with fresh uncertainty over what now counts as “normal” margins. On this day, Germany’s Beiersdorf trimmed its 2026 core operating margin target and pointed to headwinds in both U.S. retail and China’s travel retail channel. Shares tumbled more than 12%. “No growth and the potential for falling margins was a negative surprise,” one local trader told Reuters. Reuters

Travel retail is finding its way back into headlines. Travel stocks slid Monday after the U.S.-Israel flare-up with Iran rattled flight routes and sent oil higher. “Every airline is full and every flight is full,” noted Paul Charles, who runs the PC Agency travel consultancy. Extended flight disruptions can hit airport and duty-free sales—still crucial for beauty companies, even if shoppers keep spending elsewhere. Reuters

EL popped out in New York trading, shrugging off a mostly flat market. This didn’t feel like a minor slip—more of a sharp reset. That’s been the story with this stock in recent weeks.

Estée Lauder—behind brands like Clinique, M.A.C, and Jo Malone—last made headlines on Feb. 5, boosting its full-year outlook but falling short of Wall Street forecasts. The stock tumbled roughly 23% on the news. CEO Stéphane de La Faverie told Reuters the business was “navigating the complexity and volatility” in the U.S., while Evercore ISI’s Robert Ottenstein pointed out that U.S. market share gains failed to show up in retailer orders. The company stuck with its projection of a $100 million annual profit hit from tariffs and warned third-quarter margins would shrink by 50 basis points, or half a percentage point. Reuters

The same themes stick out for the stock—U.S. orders, China appetite, travel retail, and the next move on costs. No scheduled catalyst lines up this week, so the tape is left to its own devices at the open.

According to Monday’s filing, de La Faverie took possession of 5,787 vested restricted stock units, with 2,333 shares set aside for taxes instead of hitting the open market. Restricted stock units serve as equity-based compensation, transforming into actual shares once they vest.

The next payout from the company comes in at $0.35 per share, set for shareholders of record on Feb. 27 and slated to hit accounts March 16, per its dividend schedule. Short-term traders sometimes chase these dates, but lately the stock’s day-to-day moves have been much more pronounced.

But if travel disruptions drag on, the hit to duty-free sales could get worse — and things won’t improve if U.S. retailers remain conservative with orders through spring. Any steeper rise in fuel or raw material costs would further challenge the company’s efforts to defend its margins.

Estée Lauder’s fiscal third-quarter results land May 1, with a conference call set to follow. Investors will have their ears out for fresh details on tariffs, U.S. order momentum, and signs that travel retail demand is staying afloat.

Stock Market Today

  • Figma Stock Volatility Sparks Reassessment Amid Valuation Debate
    May 17, 2026, 1:04 AM EDT. Figma's share price closed at $22.92, down 39.1% year-to-date but up 21.1% over the past month, reflecting market volatility amid reassessment of growth-oriented tech stocks. A Discounted Cash Flow (DCF) analysis suggests Figma is undervalued by 18.3%, estimating intrinsic value at $28.07 per share compared to current levels. The company's high price-to-sales (P/S) ratio of 10.40x, compared to the software sector average of 3x, highlights expectations for rapid growth despite ongoing profitability challenges. Investors are advised to consider multiple valuation methods to gauge Figma's stock potential amid shifting market sentiment around design and collaboration software sectors.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
BATL stock steadies in premarket after doubling as Hormuz fears lift oil — what’s next for Battalion Oil
Previous Story

BATL stock steadies in premarket after doubling as Hormuz fears lift oil — what’s next for Battalion Oil

MARA stock jumps premarket as annual filing opens door to selling bitcoin stash
Next Story

MARA stock jumps premarket as annual filing opens door to selling bitcoin stash

Go toTop